The literature on the risks to the fetus and neonate of maternal cytomegalovirus infection, whether primary or reactivated, is briefly reviewed. The various rates of risks reported and the mechanism of fetal infection are discussed. Screening for maternal infection, antenatal diagnosis of fetal infection, and development of new antiviral treatments and immunizations are advocated.